Insulet (PODD) Depreciation & Amortization (CF) (2010 - 2026)
Insulet's (PODD) quarterly Depreciation & Amortization (CF) came in at $26.2 million in Q1 2026, up 20.74% YoY from $21.7 million in Q1 2025, and up 7.38% on a QoQ basis from $24.4 million in Q4 2025.
Insulet (PODD) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $26.2 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 20.74% year-over-year to $26.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.9 million (up 13.38% YoY) and the FY2025 annual result came in at $90.4 million, up 11.88% from the prior year.
- Depreciation & Amortization (CF) improved to $26.2 million in Q1 2026, from $24.4 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $26.2 million in Q1 2026 to a low of $15.3 million in Q1 2022.
- A 5-year average of $19.6 million and a median of $18.8 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2025 — Depreciation & Amortization (CF) climbed 3.29% — and 2026, when it increased 20.74%.
- Tracing PODD's Depreciation & Amortization (CF) over 5 years: stood at $16.2 million in 2022, then increased by 16.05% to $18.8 million in 2023, then increased by 14.36% to $21.5 million in 2024, then gained by 13.49% to $24.4 million in 2025, then increased by 7.38% to $26.2 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $26.2 million (Q1 2026), $24.4 million (Q4 2025), and $22.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Insulet | 10.42 Bn | 9.88 Bn | 562.60 Mn | 26.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.70 Mn |
| Jun 30, 2026 | 26.70 Mn |
| Mar 31, 2026 | 26.20 Mn |
| Mar 31, 2026 | 26.20 Mn |
| Dec 31, 2025 | 24.40 Mn |
| Dec 31, 2025 | 24.40 Mn |
| Sep 30, 2025 | 22.00 Mn |
| Sep 30, 2025 | 22.00 Mn |
| Jun 30, 2025 | 22.30 Mn |
| Jun 30, 2025 | 22.30 Mn |
| Mar 31, 2025 | 21.70 Mn |
| Mar 31, 2025 | 21.70 Mn |
| Dec 31, 2024 | 21.50 Mn |
| Dec 31, 2024 | 21.50 Mn |
| Sep 30, 2024 | 21.30 Mn |
| Sep 30, 2024 | 21.30 Mn |
| Jun 30, 2024 | 19.20 Mn |
| Jun 30, 2024 | 19.20 Mn |
| Mar 31, 2024 | 18.80 Mn |
| Mar 31, 2024 | 18.80 Mn |